These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 1720998)

  • 1. Reserpine-insensitive dopamine release in the substantia nigra?
    Elverfors A; Nissbrandt H
    Brain Res; 1991 Aug; 557(1-2):5-12. PubMed ID: 1720998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-Methoxytyramine formation following monoamine oxidase inhibition is a poor index of dendritic dopamine release in the substantia nigra.
    Elverfors A; Pileblad E; Lagerkvist S; Bergquist F; Jonason J; Nissbrandt H
    J Neurochem; 1997 Oct; 69(4):1684-92. PubMed ID: 9326297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Turnover of dopamine and dopamine metabolites in rat brain: comparison between striatum and substantia nigra.
    Nissbrandt H; Carlsson A
    J Neurochem; 1987 Sep; 49(3):959-67. PubMed ID: 3612134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of GBR 12909, a dopamine re-uptake inhibitor, on monoaminergic neurotransmission in rat striatum, limbic forebrain, cortical hemispheres and substantia nigra.
    Nissbrandt H; Engberg G; Pileblad E
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Jul; 344(1):16-28. PubMed ID: 1663587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of d-amphetamine on dopaminergic neurotransmission; a comparison between the substantia nigra and the striatum.
    Elverfors A; Nissbrandt H
    Neuropharmacology; 1992 Jul; 31(7):661-70. PubMed ID: 1328918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and release of dopamine in rat brain: comparison between substantia nigra pars compacts, pars reticulata, and striatum.
    Nissbrandt H; Sundström E; Jonsson G; Hjorth S; Carlsson A
    J Neurochem; 1989 Apr; 52(4):1170-82. PubMed ID: 2564423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain dialysis: in vivo metabolism of dopamine and serotonin by monoamine oxidase A but not B in the striatum of unrestrained rats.
    Kato T; Dong B; Ishii K; Kinemuchi H
    J Neurochem; 1986 Apr; 46(4):1277-82. PubMed ID: 2419508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphetamine-induced dopamine release in the rat striatum: an in vivo microdialysis study.
    Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
    J Neurochem; 1988 Feb; 50(2):346-55. PubMed ID: 2447237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoflurane anesthesia induces biphasic effect on dopamine release in the rat striatum.
    Adachi YU; Yamada S; Satomoto M; Higuchi H; Watanabe K; Kazama T
    Brain Res Bull; 2005 Oct; 67(3):176-81. PubMed ID: 16144652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for dopamine release and metabolism beyond the control of nerve impulses and dopamine receptors in rat substantia nigra.
    Nissbrandt H; Pileblad E; Carlsson A
    J Pharm Pharmacol; 1985 Dec; 37(12):884-9. PubMed ID: 2868096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of monoamine oxidase inhibition on the release of 3H-dopamine elicited by potassium and by amphetamine from the rat substantia nigra and corpus striatum.
    Arbilla S; Langer SZ
    Naunyn Schmiedebergs Arch Pharmacol; 1980 Feb; 311(1):45-52. PubMed ID: 7366741
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemistry of somatodendritic dopamine release in substantia nigra: an in vivo comparison with striatal dopamine release.
    Heeringa MJ; Abercrombie ED
    J Neurochem; 1995 Jul; 65(1):192-200. PubMed ID: 7790860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute effects of intranigral application of MPP+ on nigral and bilateral striatal release of dopamine simultaneously recorded by microdialysis.
    Santiago M; Rollema H; de Vries JB; Westerink BH
    Brain Res; 1991 Jan; 538(2):226-30. PubMed ID: 1707325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo mechanisms underlying dopamine release from rat nigrostriatal terminals: II. Studies using potassium and tyramine.
    Fairbrother IS; Arbuthnott GW; Kelly JS; Butcher SP
    J Neurochem; 1990 Jun; 54(6):1844-51. PubMed ID: 2338545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microdialysis study of the effects of the antiparkinsonian drug budipine on L-DOPA-induced release of dopamine and 5-hydroxytryptamine by rat substantia nigra and corpus striatum.
    Biggs CS; Starr MS
    Synapse; 1999 Oct; 34(1):36-46. PubMed ID: 10459170
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A microdialysis study on striatal dopamine, 5-HT and metabolites in conscious rats after various treatments: evidence for extravesicular release of dopamine.
    Wong PT; Teo WL; Lee T
    Neuroreport; 1993 Oct; 5(1):53-6. PubMed ID: 7506588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of dopamine agonists and antagonists on DOPA formation in the substantia nigra.
    Argiolas A; Melis MR; Fadda F; Serra G; Gessa GL
    J Neurochem; 1982 Jan; 38(1):75-9. PubMed ID: 6809898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation and clearance of interstitial metabolites of dopamine and serotonin in the rat striatum: an in vivo microdialysis study.
    Cumming P; Brown E; Damsma G; Fibiger H
    J Neurochem; 1992 Nov; 59(5):1905-14. PubMed ID: 1383428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a short period of vitamin E-deficient diet in the turnover of different neurotransmitters in substantia nigra and striatum of the rat.
    Castaño A; Herrera AJ; Cano J; Machado A
    Neuroscience; 1993 Mar; 53(1):179-85. PubMed ID: 7682297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of inhibition of monoamine oxidase on the levels of 5-S-cysteinyl adducts of catechols in dopaminergic regions of the brain of the guinea pig.
    Fornstedt B; Carlsson A
    Neuropharmacology; 1991 May; 30(5):463-8. PubMed ID: 1907723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.